Betaine

Betaine

SCHEMBL677352

C[N+](C)(C)CC(=O)O.C[N+](C)(C)CC(=O)[O-].[OH-]

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

BHMTBHMT2

The experimentally established mechanism targets of Betaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.70
ALDH1A1 P00352 1/20 0.67
LMNA P02545 1/20 0.67
APEX1 P27695 1/20 0.67
SLC22A16 Q86VW1 1/20 0.38
CPT2 P23786 1/20 0.35
CPT1A P50416 1/20 0.35
BBOX1 O75936 6/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
HRH1 P35367 1/20 0.31
KMT2A Q03164 1/20 0.31
CRAT P43155 1/20 0.31
FFAR3 O14843 2/20 0.31
HDAC3 O15379 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycinebetaine SCHEMBL9281697 0.87 TSHR (0.55) TSHRALDH1A1LMNAAPEX1SLC22A16
Glycinebetaine SCHEMBL7739 0.87
Betaine SCHEMBL31467313 0.87
Betaine SCHEMBL912129 0.87
Glycinebetaine SCHEMBL2803780 0.87 TSHR (0.53) TSHRALDH1A1LMNAAPEX1SLC22A16
Glycinebetaine SCHEMBL8678519 0.87 TSHR (0.53) TSHRALDH1A1LMNAAPEX1SLC22A16
Glycinebetaine SCHEMBL4900209 0.87
Glycinebetaine SCHEMBL15813100 0.85 TSHR (0.55) TSHRALDH1A1LMNAAPEX1SLC22A16
Glycinebetaine SCHEMBL8772044 0.85 TSHR (0.55) TSHRALDH1A1LMNAAPEX1SLC22A16
Betaine SCHEMBL2197253 0.84 TSHR (0.78) TSHRALDH1A1LMNAAPEX1SLC22A16

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120010077-A1 Methods for Controlling Flower Development in Plants YALE UNIVERSITY 2012-01-12 US disclosed
WO-2011011235-A1 TREATMENT OF DISORDERS ASSOCIATED WITH G PROTEIN-COUPLED RECEPTOR 35 (GPR35) TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010077-A1 Methods for Controlling Flower Development in Plants CYP17A1, STOM, ERG28 TSHR 4481/4885ALDH1A1 2844/4885LMNA 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.